why choose us

300×250 Ad Slot

Research Article: Drug Pricing of Domestic Anti-PD-L Antibody Adebrelimab: Cost-Effectiveness Analysis of the First-Line ES-SCLC Treatment in China

Date Published: 2023-11-22

Introduction:
Lung cancer remains a serious public health issue in China, with , new cases and , deaths recorded in . , Small cell lung cancer (SCLC), which is a fraction of all lung cancers (~%), represented an aggressive malignancy with a five-year survival rate of around %. SCLC is characterized by an exceptionally rapid tumor growth and strong predilection for early metastasis. SCLC is classified into limited stage disease and extensive-stage (ES) disease, with the latter accounting for more than two thirds of the SCLC…

Read more

300×250 Ad Slot